carbon monoxide has been researched along with Sarcopenia in 2 studies
Carbon Monoxide: Carbon monoxide (CO). A poisonous colorless, odorless, tasteless gas. It combines with hemoglobin to form carboxyhemoglobin, which has no oxygen carrying capacity. The resultant oxygen deprivation causes headache, dizziness, decreased pulse and respiratory rates, unconsciousness, and death. (From Merck Index, 11th ed)
carbon monoxide : A one-carbon compound in which the carbon is joined only to a single oxygen. It is a colourless, odourless, tasteless, toxic gas.
Sarcopenia: Progressive decline in muscle mass due to aging which results in decreased functional capacity of muscles.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Computed tomography-measured sarcopenia, and pulmonary function (forced expiratory volume in first second/forced vital capacity/diffusion capacity for carbon monoxide) were compared pretherapy and posttherapy." | 5.51 | CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison. ( Cools-Lartigue, J; Cunningham, M; Davern, M; Donlon, NE; Donohoe, CL; Ferri, L; Kamilli, A; King, S; Lowery, M; Moran, B; Mueller, C; Ravi, N; Reynolds, JV; Sheppard, A, 2022) |
| "The purpose of this study was to assess exercise capacity, lung and physical function in COVID-19 survivors, and the association of lesion-level characteristics assessed by chest computed tomography, probable sarcopenia, and percentage of diffusing capacity of the lung for carbon monoxide with clinical and functional variables." | 4.31 | Lung and physical function in post COVID-19 and clinical and functional associations: a cross-sectional study in Brazil. ( Almeida, KO; Alves, IGN; Gomes-Neto, M; Jezler, SFO; Moura, DM; Nascimento, WLCD, 2023) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Donlon, NE | 1 |
| Moran, B | 1 |
| Kamilli, A | 1 |
| Davern, M | 1 |
| Sheppard, A | 1 |
| King, S | 1 |
| Donohoe, CL | 1 |
| Lowery, M | 1 |
| Cunningham, M | 1 |
| Ravi, N | 1 |
| Mueller, C | 1 |
| Cools-Lartigue, J | 1 |
| Ferri, L | 1 |
| Reynolds, JV | 1 |
| Nascimento, WLCD | 1 |
| Moura, DM | 1 |
| Almeida, KO | 1 |
| Gomes-Neto, M | 1 |
| Jezler, SFO | 1 |
| Alves, IGN | 1 |
1 trial available for carbon monoxide and Sarcopenia
| Article | Year |
|---|---|
CROSS Versus FLOT Regimens in Esophageal and Esophagogastric Junction Adenocarcinoma: A Propensity-Matched Comparison.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Carbon Monoxide; Esophageal Neoplasm | 2022 |
1 other study available for carbon monoxide and Sarcopenia
| Article | Year |
|---|---|
Lung and physical function in post COVID-19 and clinical and functional associations: a cross-sectional study in Brazil.
Topics: Brazil; Carbon Monoxide; COVID-19; Cross-Sectional Studies; Humans; Lung; Sarcopenia; SARS-CoV-2 | 2023 |